Long-term trials of colchicine for secondary prevention of vascular events: a meta-analysis

Michelle Samuel; Colin Berry; Marie‐Pierre Dubé; Wolfgang Köenig; José López‐Sendón; Aldo Maggioni; Fausto J. Pinto; François Roubille; Jean‐Claude Tardif

doi:10.1093/eurheartj/ehaf174

Related publications

Article2021

Anti-inflammatory therapy in ischaemic heart disease: from canakinumab to colchicine

Felicita Andreotti, Aldo Maggioni, Alice Campeggi, Adelaide Iervolino, Giovanni Scambia, Massimo Massetti

Article2020

Low-dose colchicine in patients treated with percutaneous coronary interventions for myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

Philippe L. L’Allier, Jean‐Claude Tardif, Simon Kouz, David D. Waters, Rafael Díaz, Aldo Maggioni, Fausto J. Pinto, Habib Gamra, Ghassan S. Kiwan, Colin Berry, J. Lopez-Sendon, Wolfgang Köenig, Lucie Blondeau, Marie Claude Guertin, François Roubille

Article2019

Effect of loading dose of atorvastatin therapy prior to percutaneous coronary intervention in patients with acute coronary syndrome: a meta-analysis of six randomized controlled trials

Meletios A Dimopoulos, Barsuk A.L, Lei Shi, Rongjuan Guo, Benjamin Yang, Hongyong Cao, Leiming Luo, Lü Liang

Article2020

Long-Term Outcomes After Revascularization for Stable Ischemic Heart Disease

Mahesh V. Madhavan, Björn Redfors, Ziad A. Ali, Megha Prasad, Bahira Shahim, Pieter C. Smits, Clemens von Birgelen, Zixuan Zhang, Roxana Mehran, Patrick W. Serruys, Akiko Maehara, Martin B. Leon, Ajay J. Kirtane, Gregg W. Stone

Circulation Cardiovascular Interventions

Article2007

Statins and Stroke Prevention

Maurizio Paciaroni, Michael G. Hennerici, Giancarlo Agnelli, Julien Bogousslavsky